<scp>SOX17</scp> orchestrates immune evasion in early colorectal adenomas and cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SOX17 orchestrates immune evasion in early colorectal adenomas and cancers

Published:2024-07-23 Issue:2 Volume:173 Page:422-424
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Pei Bo¹²^ORCID,Yang Huiye³,Zhou Fuxiang¹

Affiliation:

1. Department of Oncology Zhongnan Hospital of Wuhan University, Hubei Provincial Clinical Research Center for Cancer, Hubei Key Laboratory of Tumor Biological Behaviors Wuhan China

2. Cancer Center, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University Enshi China

3. Department of Hematology Affiliated Hospital of Guilin Medical University Guilin China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13831

Reference10 articles.

1. SOX17 enables immune evasion of early colorectal adenomas and cancers

2. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

3. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer

4. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

5. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP